AACR Annual Meeting 2026
April 17-22, San Diego, CA
Booth #1823
See what’s new with RareCyte at AACR
Explore spatial biology and liquid biopsy solutions that enable you to translate biomarkers into clinical impact. See our platforms at the booth and discover how cancer researchers are using Orion and CyteFinder for biomarker development.
Meet our team at booth 1823.
Talk spatial biology and liquid biopsy, see the instruments in person, and discuss how Orion and CyteFinder can accelerate your research.
Big news is coming for spatial proteomics in clinical research.
Orion — RareCyte's spatial proteomics platform — is already redefining what's possible for spatial biomarker development. At AACR 2026, we'll be sharing a new instrument that raises that ceiling further. If your work depends on spatial proteomics at cohort scale, this is news you'll want to hear in person.
Visit booth 1823 to be first to hear the news.
Cancer research, powered by RareCyte.
Leading researchers are presenting findings powered by Orion and CyteFinder across this year's program.
SUNDAY, APRIL 19
POSTER
2:00–5:00 PM
Pashtoon Kasi, MD · City of Hope
Development of a novel CDH17 CTC assay to monitor colorectal patient blood and cerebrospinal fluid
Abstract #1082 Section 42
POSTER
2:00–5:00 PM
Ugonna Ezuma-Igwe · University of Georgia
Mapping the spatiotemporal dynamics of CD44v9 reveals a senescent cell therapy-resistant niche in pancreatic cancer
Abstract #LB009 Section 50
POSTER
2:00–5:00 PM
Xi Sun · University of Georgia
Cluster of differentiation 44 variant isoform 9 defines cancer stem cell reservoirs in pancreatic intraepithelial neoplastic spatial niches
Abstract #LB017 Section 50
MONDAY, APRIL 20
PODIUM PRESENTATION
12:35–12:55 PM
David Rimm, MD, PhD · Yale University
Pathologist’s perspective. Quantitative and reproducible assessment of ADC targets: Moving beyond conventional pathology
Session: Advances in Technologies, Hall H - Ground Level
PODIUM PRESENTATION
4:05–4:20 PM
Y.C. Kao · Frazer Institute, University of Queensland
Precision diagnostics for early melanoma detection using spatial biology and AI-guided image analysis
Abstract #4021 Room 29
POSTER
9:00 AM–12:00 PM
Haochen Zhang, PhD · Valar Labs
Association of interpretable histomorphic features with molecular markers: A Computational Histology Artificial Intelligence (CHAI) biomarker development platform analysis
Abstract #1453 Section 4
POSTER
9:00 AM–12:00 PM
Abigail G. Branch · University of Georgia
Patient-derived organoid-immune cell co-cultures and spatial biology support a CD44v9 cancer stem cell-directed therapeutic strategy for adamantinomatous craniopharyngioma
Abstract #LB124 Section 52
POSTER
2:00–5:00 PM
Jaspreet Kaur, PhD · Navigate BioPharma
Comprehensive immune landscape analysis of solid tumors using a 17-plex immunofluorescence assay in clinical trials
Abstract #3972 Section 49
POSTER
2:00–5:00 PM
Tanjina Kader, PhD · Harvard University
Integrative spatial profiling of protein and chromosomal alterations across normal, precancer, and cancer revealed the presence of aneuploidy in the normal fallopian tube
Abstract #3533 Section 33
POSTER
2:00–5:00 PM
Yana Zavros, PhD · University of Georgia
Cabozantinib remodels the pancreatic tumor microenvironment to potentiate immunotherapy
Abstract #LB234 Section 55
TUESDAY, APRIL 21
POSTER
9:00 AM–12:00 PM
Richard Van Krieken, PhD · Navigate BioPharma
Spatial immune profiling of solid tumors by complementing H&E with a novel 17-plex immunofluorescence approach
Abstract #4157 Section 3
POSTER
9:00 AM–12:00 PM
Mantasha Tabassum · University of Houston
Method development and workflow optimization of a CTC-based biomarker assay to predict response to CDK4/6 inhibitors in HR+/HER2- breast cancer
Abstract #5250 Section 42